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The purpose of this work was to determine the susceptibility of 
strains of viridans streptococci and enterococci to sulfathiasole, 
aureomycin, bacitracin, penicillin, and streptomycin; and to deter- 
mine whether their susceptibility to these agents was related to 
other biochemical properties. Since previous work had indicated 
that trained sulfathiazole-resistant viridans streptococci acquired 
properties similar to those characteristic of enterococci, it followed 
that strains trained to resistance to penicillin, streptomycin, aureo- 
mycin, and bacitracin should also be compared in biochemical proper- 
ties to naturally-resistant enterococci. Investigation of cross- 
resistance among these strains seemed of further importance because 
of its possible clinical applications.
A study of the interrelationship between susceptibility and other 
biochemical properties commonly used for the identification of the 
organisms might produce several useful results. Mew and better tests 
for identification might be discovered, possible agents for trial in 
treatment of the changed organisms might be indicated, and possible 
changes in organisms subjected to the chemotherapeutic agents might 
be anticipated. Finally, it was of interest to compare all changes 
in both the parent and the trained resistant strains for a possible
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explanation of the increased resistance. Gale had found larger 
amounts of free glutamic acid in strains of staphylococci naturally 
resistant to sulfathiazole than in susceptible strains, if the young 
cells were examined. Less glutamic acid was found in penicillin- 
resistant cells. He did not examine cells resistant to other anti- 
biotics. Therefore, the glutamic acid content of cells trained to 
resistance to sulfathiazole, penicillin, streptomycin, and aureomycin 
was determined in this study.
The work was carried out in two parts. First, the biochemical 
properties and susceptibility to sulfathiazole, aureomycin, bacitracin, 
penicillin, and streptoaycin was determined for 40 strains of viridans 
streptococci and enterococci. Thirty-seven strains of the organisms 
were isolated from pathological material and 3 strains were used as 
controls, one Streptococcus fecalis (A.T.C.C. #9790) and two viridans 
streptococci, Streptococcus "MG" and Streptococcus "SBE", Secondly, 
the biochemical properties and susceptibility to the chemotherapeutic 
agents was determined for trained resistant strains to sulfathiazole, 
aureomycin, penicillin, and streptomycin. No bacitracin-resistant 
strains were studied, as even after prolonged exposure to bacitracin, 
no resistant variants developed. The glutamic acid content was de- 
termined manometrically for viridans streptococci, enterococci, and 
resistant variants to sulfathiazole and the antibiotics.
The biochemical characteristics best suited for differentiating 
between viridans streptococci and enterococci, as indicated in this 
study, area growth in broth incubated at 45 C for 24 hours, the reduc- 
tion of 0.1% methylene blue milk, growth in 6.5% NaCl broth, and growth
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on 40% bile agar. The enterococci were more resistant to all of the 
chemotherapeutic agents used than were the viridans streptococci.
The much greater resistance of the enterococci to sulfathiazole and 
penicillin indicated the possibility of using definite concentra- 
tions of these in broth as added criteria for identification. It was 
found that all of the enterococci and none of the viridans strepto- 
cocci would grow in concentrations of 10 mg/cc of sulfathiasole in 
broth and 2 units/cc of penicillin in broth. Results of the in vitro 
tests for susceptibility to the five agents indicate that infections 
due to viridans flight respond to all of the chemotherapeutic agents 
tested, but those due to enterococci might best be treated with baci­
tracin or aureomycin.
The most interesting findings in the development of resistant 
strains were the cross—resistance and the difference between the 
streptomycin-resistant variants as compared to the others. Some 
increase in resistance to all the agents was shown by the sulfathia-z
ole-resistant variants. Increase in resistance to other agents was 
also shown by those strains trained to resistance to penicillin and 
aureomycin, but this was not generally true of the streptomycin- 
resistant strains. The variant strains selected by sulfathiasole, 
aureomycin, and penicillin all showed the same biochemical properties 
as a typical enterococcus. Those selected by streptomycin varied in 
their biochemical properties and often did not have the properties of 
enterococci.
The results of the glutamic aoid determinations showed that 
appreciable amounts are found free inside those cells which have 
acquired sulfathiasole resistance. Whether this resistance has been
abstract-4
induced by sulfathiazole or accompanies increased resistance to other 
agents makes no difference. Whether the resistance is due to the 
increase in internal glutamic aeid or whether this is merely a re- 
suit of other changes which determine the organism's resistance, is 
not answered by this study. The viridans streptococci tested, and 
the streptomycin-resistant variants showed no free glutamic acid at 
any stage of growth.
This abstract of about 750 words is approved as to form and content.I recommend its publication.
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INTERRELATIONSHIPS BETWEEN BIOCHEMICAL PROPERTIES AND SUSCEPTIBILITT 
TO ANTIBIOTICS AND SULFATHIAZOLE OF STRAINS OF VIRIDANS STREPTOCOCCI
AND ENTEROCOCCI
I. INTRODUCTION 
It has previously bean shown (Clapper and Heatherman, 1948 and 
1950) that trained sulfathiasole—resistant strains of Streptococcus 
gjtis possessed biochemical properties similar to those characteristic 
for enterococci. It seemed of Interest, therefore, to determine the 
susceptibility of strains of viridans streptococci and naturally-* 
resistant enterococci not only to sulfathiasole but to the better 
known antibiotics as well, and to determine whether their suscepti­
bility to these agents was related to other biochemical properties as 
sulfathiasole resistance had been found to be in the trained strains.
As a corollary to this study, it followed that strains trained to 
resistance to penicillin, streptomycin, aureonycin, and bacitracin 
should be compared in biochemical properties to sulfathiazole-resis- 
tant strains and to the naturally-occurring enterococci. Investiga­
tion of cross-resistance among these strains sewed of further im­
portance because of its possible clinical applications.
Changes in biochemical properties that sccoutpany changes in 
resistance to chemotherapeutic agents may make for even greater con­
fusion in identification or classification than that which already 
exists in the viridans group. A study of the interrelationship be­
tween susceptibility and other biochemical properties consaonly used 
for the identification of the organisms may produce several useful
1
results. Hew and better tests for identification may be discovered, 
possible agents for trial in treatment of the changed organisms may 
be indicated, and possible changes in organisms subjected to the 
chemotherapeutic agents may be anticipated.
Finally, it was of interest to compare all changes in both the 
parent and the trained-resistant strains for a possible explanation of 
the increased resistance* It was for this reason that the determina­
tion of glutamic acid in cells of all classes was made. Gale had 
found larger amounts of glutamic acid in strains of staphylococci 
naturally resistant to sulfathiaaole than in susceptible strains, if 
the young cells were examined. Less glutamic acid was found in 
penicillin-resistant cells. Cells resistant to other antibiotics 
were not examined.
the glutamic acid content of cells trained to resistance to 
sulfathiaaole, penicillin, streptomycin, and aureomycin was therefore 
determined in this study.
t
II. REOTT OP THE LITESATO3E 
Viridans Streptococci and Enterococci
Thera have been many tests used for the differentiation of the 
viridans streptococci from the enterococci and much disagreement 
among the workers in this field as to the value of certain tests. 
Since Houston and MeCloy (1913) first noted the great resistance of 
the enterococci to temperature changes, investigators have tried, 
with little success, to correlate the resistance of enterococci 
with fermentative ability, serological reactions, cultural character­
istics, biochemical characteristics, and susceptibility to certain 
bacteriostatic agents. Studies have been made on the sensitivity of 
both the enterococci and viridans streptococci to the various anti­
biotics and the sulfonamides with each investigator often using 
different criteria for the classification of each group.
Enterococci were first separated froa the better known pyogenic 
group of streptococci by MacCallua and Hastings (1899). They iso­
lated a streptococcus from a case of acute endocarditis, described 
its appearance on different media, and separated it from the pyo­
genic streptococci by the reaetion it produced in litmus milk. They 
attributed the reaction in litmus milk to milk—curdling and proteo­
lytic enayaes, which were separable from the cell and capable when 
isolated of producing their effects in milk. It is interesting that 
litmus milk still is used today by many investigators as a 
differential test between viridans streptococci and enterococci, 
although In the experimental data given later, this test was found to 
be quite variable in each group.
Probably the first attempt to place the viridans streptococci 
into a group apart from the enterococci and other streptococci was 
made by Andrewes and Border (1906), They studied 1,200 strains of 
streptococci from various sources and made seven divisions. Ctae of 
these divisions is called S. altis, a non-committal ter® picked to 
express its non-virulent character? and another division which in­
cluded intestinal streptococci, called S. fecalis. The tens entero­
cocci was first used by Thiercelin (1899), a Frenchman, to describe 
the same type of organism that Andrewes and Border called S. fecalis. 
These two investigators used what they referred to as "Gordon’s 
Metabolic Tests" which consisted of changes in litmus milk, neutral 
red broth, and the production of acid from seven different carbo­
hydrate media. In discussing these "Metabolic Tests", Gordon (190S) 
states that here is a series of definite tests for differentiating 
streptococci by their biochemical properties. Thus, as early as 
1905, the biochemistry of the bacterial cell was considered important 
in classification. Holman (1916) combined Gordon's fermentation 
»tests and Shottmueller's descriptions of growth on blood agar (1903) 
to separate the streptococci into two large groups, the hemolytic 
and non-hemolytic, with each group having eight subgroups. S. mitis 
and S. fecalis were included under the non-hemolytic group and were 
differentiated by the fermentations of mamitol and salicin. Today 
it is known that hemolytic strains can be found among the S. fecalis. 
Evans and Chinn (1947), and that fermentation of salicin and 
mannitol are variable for each group, Swift (1948). However, this 
is one of the first attempts of an investigator to correlate bio­
s
chmical with cultural characteristics of streptococci.
Because of the increasing occurrence of non-hemolytic strepto­
cocci in intestinal infections, Xruaareide and Balentine (1916) studied 
the agglutination and cultural relationships of members of the so- 
called "Streptococcus viridans p*oupB, they cohered organisms fro® 
endocarditis and other pathological conditions with strains from ton­
sils of healthy individuals, and concluded that this was a hetero­
genous group, and different strains might shoe some relationship one 
to the other, but there were no common properties shown by all the 
pathological types as compared to the control group. Bible (1921) 
described the enterococci more concisely than had been done up to that 
time. To differentiate them from the viridans group, he made use 
of their resistance to 60*C for 50 minutes. He also mentioned that 
he had found some S. mitis strains which were thermal-resistant by 
this test, and that they might be variants of the enterococci. This 
seems to be the first mention of a possible evolutionary relation­
ship between the viridans streptococci and the enterococci. Later 
(1935) Kleckner in a study of fecal streptococci found that there 
were many strains which would not tolerate exposure to S0*C for SO 
minutes. Laneofield (1925) studied iamunologieal relationships and 
chemical constitution of the viridans group, and concluded that there 
was considerable difference in the protein from different strains. 
Althou^i much work has been done on this phase since 1925, no 
successful serological classification of the viridans group has been 
made (Lancefield, 1953} Solowey, 1942 and 1945j Wheeler and Foley,
1945).
A very co/aprehensive stw$y of 150 strains of enterococci was 
carried out by Bagger (1926). Fifty*-eig£t strains were isolated from 
normal intestines and 92 strains from cases of appendicitis. In this 
investigation the resistance of the enterococci to antiseptics was 
pointed out. Phenol and formalin were the agents used. The resis­
tance of the enterococci to bacteriostatic agents was again noted by 
Chapman (1956), He found they were more resistant than E, coll, 
staphylococci, and other streptococci to a 1*500,000 dilution of 
merthiolate and a 1x2,500 dilution of phenol. This is another early 
instance of the recognition of resistance of enterococci to anti­
septics and chemotherapeutic agents. Two new tests, modifications of 
which are widely used today, were introduced in 1929. They have proven 
most valuable in differentiating the viridans streptococci from the 
enterococci. The first of these was the use of a 1*5,000 dilution of 
methylene blue in milk (Avery, 1929), and the second, the use of 40% 
bile blood agar. The latter test differentiated enterococci from 
viridans streptococci as well as certain other groups of streptococci 
(Belenky and Popova, 1929). Today the use of 0.1# methylene blue 
milk and 40$ bile agar plates differentiates very well between 
viridans streptococci and enterococci, and correlates with the resis­
tance of the two groups, as will be shown later.
Sherman, Mauer, and Stark (1937) studied 454 cultures of S. 
fecalis and made use of more extensive tests for characterisation than 
had ever been used before. They concluded that fomentation tests 
were of minor value, but that of primary differential value were 
thermal resistance, changes in litmus milk, growth in broth pH 9.6,
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and with 6.5# NaCl, and in 0.1$ methylene blue milk. In any definition 
of the S, fecalis today these teats are all still included,
The viridans streptococci were described a3 having at least taro 
definite species by Safford, Sherman, and Hodge (1937)» S, sallvarius 
and S. adtis. Hivan, Smiley, and Sherman (1941) showed that the 
property of S. salivarius to produce vary distinctive large mucoid 
colonies on 5# sucrose agar seemed to be correlated with the ability to 
ferment inulin. Concerning the non-hesaolytic streptococci of the 
viridans type, Sherman et al. (1943) wrote, "As compared with the other 
major groups of the streptococcus genus, the taxonomy of the viridans 
streptococci is in a highly unsatisfactory condition! but the comsion 
Impression that the viridans streptococci compose a heterogenous con­
glomeration is largely due to the general failure to determine the 
basic nature of the organisms dealt with.® Since this was written, 
much more has been learned about the basic nature of these organisms 
due to the use of the antibiotics which has stimulated intensive 
study of many phases of the metabolism of these organisms. Probably 
in the near future some very fundamental differences in metabolism be­
tween the viridans streptococci and enterococci will be disclosed,
Mirick et al. (1944) described a new type of viridans streptococci 
which they called Streptococcus "MO". This organism was consistently 
isolated from a group of patients who had primary atypical pneumonia. 
This viridans type of streptococci differed in some of its biological 
characteristics from S. ndtis, S. salivarius, and from the enterococci* 
Two identifying characteristics of this group of organisms were the 
formation of small fluorescent colonies on &% sucrose agar and capsular
7
swelling of all strains in the presence of specific immune rabbit 
serum.
Studying the serology of the enterococci, Foley and Wheeler 
(1945) found no correlation with biochemical tests but did find that 
the <mly characteristics common to the whole nroup were the reduction 
of 0.1$ methylene blue milk and growth in 6.5^  HaGl broth. They also 
found that only 1($ of the group were thermal-resistant and, there­
fore, concluded that this property was unreliable to use as a differen­
tial criterion.
fthite and Niven (1946) described the biochemical characteristics 
of a new type of viridans first isolated by Loewe et al. (1946) from 
cases of subacute bacterial endocarditis. As with Streptococcus "MGn 
this group of organisms seemed to have characteristics intermediate 
between those of the viridans streptococci and the enterococci. 
Streptococcus "SBE" as this new type was named by Loews, had toe 
unique property of synthesising a polysaccharide in B% sucrose broth 
which caused a jelling of the medium. It also hydrolysed arginine and 
fermented inulin but not raffinose, and grew on 4Q$ bile agar but not 
in 6,5% Nad broth. Swift (1948) presents all of the most widely used 
biochemical tests for the viridans streptococci and the enterococci In 
tabulated fora, and this served as the basis for the differential 
tests used in this study.
Fleming (1929) noted that S. fecalls was very resistant to the 
antibacterial action of his penicillin cultures while viridans strepto­
coccus was very susceptible. However, the first example of an in­
vestigator trying to show a relationship between biochemical reactions 
and sensitivity to antibiotics is found in the work of Bornsteln
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(1940). He studied the action of penicillin on enterococci and viridans 
streptococci and found that in penicillin broth all of his enterococci 
grew and the ■viridans streptococci did not* The exact concentration 
of the penicillin broth cannot be determined from his data, and no 
suggestions were given as to aixy practical application of this fact*
The penicillin resistance of enterococci was made use of by ihite and 
vBieraan (1944), who devised a selective medium containing 525 units/ 
liter of penicillin that prevented the growth of most of the organ­
isms in milk except the enterococci*
Dawson, Hobby, and Lipaan (1944) determined the penicillin 
sensitivity of SO strains of non-hemolytic streptococci isolated from 
eases of subacute bacterial endocarditis. Among the 50 strains, 19 
were described as viridans streptococci, and 5 resembled enterococci. 
Penicillin in concentrations of .01 to .05 units/ec prevented growth. 
They concluded that the degree of sensitivity of any particular 
strain did not correspond with the cultural or serological properties 
of the strain. Watson (1944) determined the penicillin levels of 8 
strains of Lancefield Group D Enterococci, and found 2.0 to 5.0 
units/cc to be Inhibitory, Massell, Heyeserian, and Jones (1946) 
carried out experiments with penicillin to see what effect varying 
the size of the inoculum would have on the sensitivity levels of 
viridans streptococci. They found that within wide limits, variations 
in the number of exposed organisms did not alter the concentration 
required to prevent growth. This concentration was found to be from 
.4 to ,055 units/cc. They also found that by using both penicillin 
and different sulfonamides together, the concentration of penicillin 
necessary to inhibit growth was decreased by 25-75*.
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Penicillin-resistant non-heraolytlc streptococci irere shown by 
Keleney and Johnson (194?) to be sensitive to bacitracin. Chandler 
and Bliss (1048) found that 6 strains of S. fecalis were nore suscep­
tible to aureamycin than penicillin. This was also shown by Bliss 
and Todd (1949), who obtained inhibiting concentrations of aureo- 
Jaycin of .62 to 1.25 mg/cc as compared to 2.5 units/cc for penicillin. 
Jawitz and Gunnison (1950) obtained penicillin sensitivity levels for 
viridans streptococci of 1.0 units/cc and 2.5 to 5.0 units/cc for 
enterococci.
Increased Resistance and Biochemical Changes
Sulfonamide Re-si stance!
Several investigators have reported changes occurring in the 
properties of bacteria made resistant to the various sulfa drugs.
One of the first studies made on the effect of increased resistance 
of bacteria to sulfonamide was carried out by WcClean et al, (1959). 
They found that thoy could increase the tolerance of pneumococci to 
sulfonamide both in vivo and in vitro. The virulence of the parent 
and resistant strains was the same. MacLeod (1959) studied the 
differences in metabolism of "sulfapyridlne-fast’ strains and parent 
strains of pneumococcus Type I, Be found no changes in morphology, 
type-speclficity, virulence, or fermentations. However, the production 
of HgOg, a product of aerobic metabolism in the pneumocoecus, was 
greatly reduced in the resistant strain. He found also that the 
resistant strain had lost dehydrogenase activity for glycerol, lac­
tate, and pyruvate. Clapper and Heatheraan (1948) found that viridans 
streptococci in becoming sulfathiaaole-resistant no longer produced 
HgO^, and that the dehydrogenase activity of the resistant strains was
increased.. Vi vino and Spink (1942) observed sulfonamide-resistant 
strains in vivo. On treating two patients with bacteremias caused by 
StaphylococcU3 aureus with sulfonamide, cultures taken after a series 
of treatment were significantly more resistant than those taken before 
sulfonamide therapy. Hamburger (1942) also noted this in vivo develop­
ment of resistance in a patient with pneuraococcic endocarditis, the 
resistance of the pneumococcus went from 2.S mg to 80 mg in 1SS days. 
Seeley and Schmidt (1942) compared resistance developed to 3 different 
sulfonamides by pneumococci. They used sulfanilamide, sulfapyridine, 
and sulfathiazole and found that when their strains became resistant 
to one sulfonamide they were more resistant to the others, also. They 
found that the different strains developed resistance at different 
rates. However, Colebrook (1943) found that of 7 strains of hemolytic 
streptococci developing resistance to sulfanilamide, only one became 
more resistant to sulfapyridine, sulfadia*ine, and sulfathiazole.
Interrelationships of drug-resistant strains were studied by 
McIntosh and Selbie (1943). They used a hemolytic streptococcus,
Group A, and a Staphylococcus pyogenes, and developed resistant strains 
to proamidine, proflavine, quindoline, and penicillin. They found no 
cross-resistance between penicillin and sulfanilamide, but did find it 
between proamidine and proflavine. Tillett et al. (1943) found that 
penicillin was effective in mice against a sulfonamide-fast pneumo- 
coccus which had been isolated from a clinical case. The change in 
biochemical characteristics and resistance of penicillin-resistant 
cultures of staphylococci, pneumococci, and hemolytic streptococci 
was studied by McKee and Houck (1943). They found that over a period 
of 3 months by transferring their cultures in broth plus increasing
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concentrations of penicillin, they obtained a six fold increase In re­
sistance for the pneumococci, a 1,000 to 6,000 fold for the staphylo­
cocci, and a 50 fold increase for the streptococci. TTith increased 
penicillin resistance there was a marked decreased virulence for alee 
and a decreased rate of growth, while the bile solubility, carbohy­
drate fermentations, and sulfonamide-rosi stance remained the same. 
Felsenfeld (1943) found that with Shigella sonnei the colony forms with 
the greater fermentative activity were more resistant to the siilfona- 
aides, . « ' ' *
There have been many reports (reviewed by Sevag, 1946) of the 
reversal of the action of sulfonamides by PAEA. This would suggest 
the possibility that sulfonamide resistance might be accompanied by an 
increased production of PAEA. Spink et al. (1944) found that sulfona­
mide-resistant strains of staphylococci produced more PABA than sensi­
tive strains. However, all resistant strains do not produce PA8&. 
Tegian et al. (1946) studied changes which developed in Mycobacterium 
ranae with sulfonamide resistance. They found that the resistant 
variant grew slower and was more susceptible to CuS04, zephiran, and 
acriflavin. Clapper and Heatherman (1950) studied the biochemical 
changes of viridans streptococci made resistant, in vitro, to sulfa- 
thiazole. With increased resistance the viridans streptococci acquired 
ability to grow on 4C$ bile agar, in 8,5% HaCl, and to reduce 0*1$ 
methylene blue milk, all of which are properties shown by enterococci. 
Sulfathiazole-resistant strains also increased in resistance to peni­
cillin, streptomycin, aureomycin, find bacitracin. However, in strepto­
mycin-resistant strains the biochemical changes were variable, and re­
sistance to sulfathiasole and the other antibiotics did not take place.
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IMs is confirmed in this study, as will be shown later. Harrison and 
Clapper (1950) found that the vitamin requirements for trained sulfa- 
resistant strains were different than for the parent-sensitive strains. 
The sulfathiazole-resistant variants and also a strain of S. fecalis5 «** ...1,1
required pteroylglutamic acid (PGA), while the parent strain did not.* ■“ :i ; ; * ; \ ■; ; ; . ■ ■ ! ■ . - * ; ; ■:( V ■ ; ■* .■ -v : ' j "* ; 1 ■ \ o',
Penicillin Resistance:
Changes accompanying the development of resistance to penicillin 
have also been reported. One of the earliest of these studies was 
reported by Abraham et al. (1941), who found that Staphylococcus 
aureus could become resistant to penicillin in vitro. By transferring 
the staphylococcus for 7 weeks in increasing concentrations of peni­
cillin, the resistance was increased 1,000 fold. A decrease in growth 
rate and enzyme activities were noted, Raramelkamp aid Maxon (1942) 
also increased the resistance of Staphylococcus aureus to penicillin 
*2 *ltgo from .04 units to 5.7 units/cc. Urby (1944) extracted a 
penicillin inhibitor from 7 strains of resistant staphylococci iso­
lated from clinical material and at the same time found that 7 strains 
of sensitive staphylococci did not produce any of this inhibitor.
Bondi and Dietz (1946) in studying the properties of penicillinase 
found that only 14$ of the more resistant staphylococci produced this 
ensyme and, therefore, came to the conclusion that the inability of 
an organisea to produce penicillinase was not an indication of the 
organism's sensitivity to penicillin. Spink and Perris (1947) studied 
penicillin-resi stant staphylococci and found that resistant strains 
produced in vitro possessed no penicillinase while naturally-occurring 
resistant strains did.
IS
Graessle tod Frost (194S) studied the Induced to vitro resistance 
of 6 strains of Staphylococcus aureus to penicillin and streptomycin. 
Two of the penicillin-resistant variants increased in resistance to 
streptoaycin but there was no increase in penicillin resistance for 
the streptomycin-resistant variants. Scene of the streptcroycto-rcsis- 
taat variants showed a reduction in the rate of carbohydrate fermen­
tations* Bellamy and Klimek (l?-*7) found that a Staphylococcus aureus 
strain which had increased in resistance to penicillin 60,000 fold 
lost its ability to grow anaerobically and grew at a slower rate than 
the parent strain. They suggested that penicillin might interfere with 
an essential step in anaerobic metabolism.
Penicillin-resistant variants of Group A, B, and C beta-hemolytte 
streptococci which had been developed in vitro were examined by Gezon 
(1948). He found that with increased penicillin resistance there was 
a decrease in virulence for mice, a loss of specificity in the group 
antigen by some, and transient changes in the type of hemolysis,
Bellamy and Klimek (1048) observed biochemical changes in penicillin- 
resistant staphylococci. They found that with an increase in resis­
tance of from 250 to 80,000 fold, there was a progressive loss in 
physiological functions including the power to ferment sucrose, lac­
tose, galactose, maltose, and taannitol. They also found that the 
strain which was 30,000 times more resistant than the parent strain no 
longer required nicotinamide as a growth factor. 'Hie resistant variant 
could be made susceptible again by growing in a medium deficient in 
amino acids. From results such as this it is very easy to see the 
rationale behind studies done on resistance in which the differences 
in biochemical characteristics and growth requirements are studied.
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Hirseh et al. (1948) obtained fro© patients viridans streptococci 
which increased in resistance to penicillin, in vivo, from 2 to 2,048 
fold. Changes in the general physical-chemical state of the organ­
isms were noted but no specific changes were given. Gezon and Fason 
(1948) studied antigenic and ensyae changes in beta-heiaolytic strepto­
cocci made resistant to penicillin, streptomycin, aureagycin, and baci­
tracin. After 40 transfers of the streptococci in suitable broth, the 
greatest increase In resistance was that for streptomycin. Penicillin 
and streptonycin were found to alter the behavior of the streptococci 
to a much greater extent than aureooycin or bacitracin. Hth Increased 
penicillin and streptomycin resistance there was a decrease la general 
ensyae activity, while with aureooycin and bacitracin resistance 
there was little change from the parent strain. Changes in the produc­
tion of streptolysin S, streptokinase, proteinase, and ribonuclease 
were studied. Kichols and Needham (1949) found that 54 penicillin- 
resistant staphylococci, isolated from bacteremias, were sensitive to 
aureooycin.
Streptomycin Resistance:
Miller and Bohnhoff (1946) developed streptomycin-resistant 
strains of gonococci and menlngocococci in only 4 to 6 transfers with 
an increase over the parent strains of more than 5,000 fold. They 
found, however, that the streptomycin-resistant strains were suscep­
tible to penicillin. In an investigation of streptomycin resistance 
in staphylococci Chandler and Schoenbach (1947) found that in the 
early logarithmic stage of growth, highly resistant mutants could be 
isolated by chance selection in a single transfer. Increased resis­
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tance to streptomycin was maintained on subculture in 3treptomycin- 
free media and the organisms retained their original virulence.
Berkman et al. (1948) studied the absorption of streptomycin by 
streptomycin-susceptible and resistant bacteria using strains of 
Staphylococcus aureus and Shigella dysenteriae. Ho difference between 
the resistant and susceptible strains was found. The metabolic 
properties of streptomycin-resistant and streptomycin-dependent 
strains of E. coll were studied by Smith at al. (1949). The resistant 
variants differed from the parent strains in that the resistant 
strains required lysine and no longer possessed an enzyme capable of 
causing the oxalacetate-pyruvate condensation in the citric acid cycle.
Aureomycin Resistance*
Paine et al. (1948) changed the resistance of Klebsiella pneumoniae 
iS from 6.2 mg to 25 mg/cc after 42 subcultures in broth con­
taining aureomycin. One strain of S. mitis developed resistance to 
12*5 mg/cc as compared to the 1.5 mg/cc in the parent strain after 21 
subcultures. However, another strain showed no increase in resis­
tance after 60 subcultures. They also found that aureomycin was as 
effective against penicillin-resistant as penicillin-sensitive staphylo­
cocci. The same was true for streptomycin-resistant staphylococci.
Qeson and Fason (1950) studied aureomycln-reslstant variants of beta- 
hemolytic streptococci developed in vitro. Resistance was increased 
among 25 strains of Group A, B, and C hemolytic streptococci 2 to 60 
fold. Three strains lost their virulence for mice while the rest 
remained about the same. Only one of the 29 strains lost its ability 
to react with group specific serum. Increased aureomycln resistance
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altered the enzymatic aetabolisa less than penicillin or streptoaycin 
resistance. One strain had decreased streptokinase activity and 2 
strains had decreased ribonuclease activity. Ho development of aureo- 
ugrcin resistance in vivo has been noted as yet.
Bacitracin Resistances
Stone (1949) increased resistance to bacitracin in vitro in 4 
strains of Staphylococcus aureus 50 to 60 fold. There was no increase 
in penicillin resistance in these strains* The bacitracin-resistant 
variants rapidly returned to their original sensitivity on subculture 
in bacitracin-free media. In this stutfy after about 90 transfers, 
viridans streptococci strains did not show any increase in resistance 
to bacitracin.
1?
Glutamic Acid and Resistance
Gale (1945) found that certain species of bacteria contain 
ensymes specific in decarbosyLating six amino acids. Clostridium 
welchii SB 12 was found to contain only the ensymes capable of decarbox- 
ylating glutamic acid. Ey using this organism as the source of the de­
carboxylase it was possible to determine quantitatively the free 
glutamic acid inside any bacterial cell. Oram positive organisms, 
which require glutamic acid preformed, were found to accumulate the 
acid, while gram negative organisms which do not require it, did not 
show any evidence of its presence inside the cell (Gale, 1947 a). The 
possibility that certain growth inhibitory agents, particularly active 
against gram positive organisms, might be exerting their action by 
preventing the assimilation of glutamic, and other acids, through the 
cell wall, occurred to Sale. This was found to be the case with
penicillin (Gala and Taylor, 1947). With sulfathiazole, however, there 
was no interference with the passage of glutaaslc acid into the cell 
but the condensation of the acid into peptides and protein was pre­
vented (Gale, 1947 b). Gale (1948) showed that in the early growth 
phase of staphylococci, two sulfathiasole-resistant strains had a 
higher content of glutamic acid than the two susceptible strains.
This relationship did not hold in the later stages of growth. An 
attempt was made to correlate glutamic acid content with penicillin 
resistance, but no such relation could be shown. The penicillin- 
resistant strains which bad been increased in resistance several 
thousand fold, however, became gram negative and lest their ability 
to concentrate free glutamic acid inside the cell (Qale and Bodwell, 
1949).
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III. EXPESIIISiTAL DATA
Introduction
Evidence has been presented that strains of viridans streptococci 
at a certain level of sulfonamide resistance (developed in vitro) 
acquired the biochemical properties characteristic of enterococci.
It seemed of interest, therefore, (A) to determine whether there was 
ai*y relationship between biochemical properties and resistance to 
antibiotics and sulfathiasole of viridans streptococci and entero­
cocci isolated from human sourcesj and (B) to study the same rela­
tionship among trained strains made resistance to the chemothera­
peutic agents in vitro.
(A) Viridans streptococci and Enterococci Isolated from Human Sources 
Methods
Forty strains of non-hesaolytic streptococci were used in this 
study. Thirty-seven strains were secured from the Bacteriology 
Laboratory of Colorado General Hospital, and S other strains were 
used as control organisms. The source of each culture is given in 
the following tablet
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Source Viridans Type Enterococcus Total Ho
Blood culture 34, 39, 40, 56 35, 42, 45, 54 8Urine culture 27, 48, 70 52, 68, 69 6Hose and throat cult. 1, 4, 6, 11, 16, 17, 18 7Bronchial washings 48, 78 49 3Uterine swab 25, 50, 58 3Pus from thigh 23 47 2Bone marrow 74 1Colostomy opening 51 1Pericardial swab 57 1Pericardial sac 66 1Rectal abscess 62 1Spinal fluid 77 1Vaginal swab 30 1Heart vegetation 55 1Amer. Type Culture 
Collection S. fecalis 9790 1P. L. Horafall Streptococcus »M0» 1H. W. Seeley Streptococcus "SBE" 1
The tests for growth in broth and determinations of bacterio­
static concentrations were performed in Tryptose Phosphate Broth (TPS) 
(Bifco) plus 0,1? Teast Extract (Bifco) at pH 7.2. Si carrying oat the 
various biochemical tests used for classification, one drop of an 18*
24 hour culture was inoculated into the appropriate media and incubated 
for 24 hours or longer if needed, as indicated later. All tests were 
done in triplicate. The biochemical tests used for separating the 
viridans streptococci from the enterococci were the following*
(1) Growth after exposure to 60*0 for 30 minutes. (Shattock and 
Mattick, 1944) Each organism was inoculated into S cc of TPB 
and put in a 60*C water bath for 30 minutes and then removed and 
Incubated at 87*C for 18-24 hours. Positive tests were considered 
as any visible growth in the tube. If there was any doubt as to 
the turbidity indicating growth, the broth was subcultured on 
blood agar plates.
(2) Growth at 10°C. (Sherman, abs. 1957} Each organism was inoculated 
into 5 cc of TPB and placed in the refrigerator at 10*C for 24 
hours, the test was considered positive by the same criteria as 
indicated for the 60*C test.
(5) Growth at 45*C. (Sherman, abs. 1937) Each organism was Inoculated 
into 5 cc of TPB and incubated in a 45*C water bath for 24 hours. 
The test was considered positive by the same criteria as indicated 
for the 60*C test.
(4) Litmus Kilk. (llacCallum and Hastings, 1899 ) 5 cc were inocu­
lated with 1 drop of the culture and the reaction was considered 
positive if the litmus milk became acid first and then curdled, 
followed by reduction of the litmus.
(5) Growth at gH 5.6. (Shattock and Hirsch, 1947j Sherman and Stark, 
1954) 1® KaOH was added to Difco Brain Heart Infusion Broth and 
the pH adjusted. Tryptose Phosphate Broth was not used here, as 
toe high pH precipitated out some of the phosphates and made it 
an undesirable media. Visible growth in 5 cc of pH 9.6 broth con­
stituted a positive test.
(6) 0.1^  methylene blue milk. (Sherman, Mauer, and Stark, 1957) 
Methylene blue was added to fresh skim milk to make an 0.1£ 
concentration and the pH adjusted to 7.2. The test was considered 
positive if the milk curdled and toe dye was reduced.
(7) Growth in 6.5^  IlaCl. (Sherman, Mauer, and Stark, 1957) Had was 
added to TPB to a concentration of 6.5^ . Any visible growth was 
read as a positive test.
(8) Growth on 40g bile agar. (Evans and Chinn, 1947) Difeo Bacto- 
Qxgall Solution was added to TPB agar to make a concentration of
£1
40^ bile. One loopful of a 24 hour broth culture was streaked on 
a plate and any visible growth on the agar plates after incuba­
tion was considered to be a positive test*
Four tests were used to differentiate the sore common so-called 
"viridans” species: S. mltls (Sherman, 1987), S. salivarlus (Sherman, 
Hiven, and Smiley, 1943), Streptococcus "SBB" (Ihite and Hiven, 1946), 
and Streptococcus "MG11 (Mirick, Thomas, et al., 1944, and Swift, 1948). 
These four tests were performed as follows*
ft) M  sacr03e a^ar. (Hiven, Sailey, and Sherman, 1941) Five per 
cent sucrose was added to nutrient agar and plates made. Sach 
viridans culture was streaked on the plate and incubated for 24 
hours and the type of colony growth was noted. This test is 
diagnostic for S. salivarlus as it is the only viridans type which 
fonas very large typical mucoid-like colonies. It is also used 
for Streptococcus "MO" which grows in very small colonies that are 
fluorescent to ultraviolet light. However, the one culture of 
Streptococcus "MG" used did not do this.
(2) 5% sucrose broth. (Niven, Kizuita, and White, 1946) Five per 
cent sucrose was added to a nutrient broth and inoculated with 
1 drop of an 18-24 hour culture of the organism and incubated 
for 7 days. "Jelling" of the broth, or increased viscosity, is 
considered to be a positive test. This test is diagnostic for 
Streptococcus "SB£".
(5) Fermentation of inulin. Inulin and broa cresol purple in the con­
centration of 1$ each were added to nutrient broth. Production 
of acid was considered a positive test. This fermentation is
quite important when combined with B% sucrose agar, 5% sucrose 
broth, and the production of ammonia in differentiating the types 
of viridans streptococci.
(4) Production of aaaonia. (Mirick, Thomas, et al., 1944) A 4$ 
peptone nutrient broth was inoculated and incubated at 37*C for 
4 days. Ammonia was considered produced when the supernatant 
liquid mixed with Kessler’s reagent gave a darker color than a 
control tube of uninoculated medium plus Kessler*s reagent. This 
test was carried out on only 8 of the cultures, as it is of value 
in determining the difference between Streptococcus ”SBEn and 
Streptococcus *M0", and only for these 6 cultures was this a 
possibility.
The sensitivity of each organism to antibiotics and sulfathiazole was 
determined. The sensitivity tests were performed in 5 cc of TPB 
containing various concentrations of the antibiotics, dilutions being 
five fold. All determinations were done at least In triplicate. The 
antibiotics used were*
(1) Sodiura sulfathiasole - Merck
(2) Aureomycin HC1 - Lederle Laboratories #
(3) Bacitracin - The Upjohn Corapany *
(4) P'Knicillin 0 Potassium - Squibb
(5) Streptomycin sulfate - Squibb
An 18-24 hour culture of each organism was diluted 1*1,000 and 
1 drop from a 1 cc pipette was used for inoculation. The inoculum
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* The author is indebted to the Lederle Laboratories for kindly 
supplying the Aureomycin and to The Upjohn Company for the Bacitracin.
sise of the viridans streptococci and enterococci cultures was adjusted 
to the same turbidity by visual inspection before diluting 1*1,000.
This equalisation was necessary because of the much more rapid growth of 
the enterococci as compared to the viridans streptococci for the same 
amount of time. All tests were incubated for 18-24 hours at 37*C 
and the level of inhibition was considered as the lowest concentration 
completely preventing growth. In the case cf very slow growing organ­
isms the result was read whenever the control tube containing no anti­
biotic or sulfathiasole showed good growth.
Besuits
Biochemical Tests Used for Classification and Their Correlation
The results are shown in Table I. The 27 viridans streptococci 
are listed first, and then the 15 enterococci. The first 8 viridans 
streptococci listed are the ones used to make resistant variants, in 
vitro, which are discussed later in Part B,
From Table I it can be seen that of the 5 temperature tests for 
resistance, growth at 45*C is the only one which appears to be of much 
value under the conditions of our experiments. This does not agree 
with the findings of some workers, particularly for enterococci 
(Sherman, abs. 19S7j Sherman, Mauer, and Stark, I95?j Sherman, 1958) 
but does agree with others (Shattock and Hirsch, 1947). All entero­
cocci are usually listed as being resistant to 60*C for one-half hour, 
and growing at 10*C for 24 hours. Of the 15 enterococci listed here, 
only 7 or about 60£ grew after holding at 60*Cj and only 4 or about 
501 grew at 10*C. Only 1 culture of the 27 viridans grew at 45*0
TABLE I
Biochemical Characteristics of Viridans Streptococci and Eni
VIRIDANS STREPTOCOCCI
Culture # .. 1 4 6 17 25 27 54 57 11 16 18 25 50 59 40 46 48 50 55 56 58 62 70 74 78 MG
60*C - | hr 0 0 0 0 0 ♦ 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
10*C 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
45*C 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ♦ 0 0 0 0 0 0
Litmus Milk 0 0 0 ♦ ♦ ♦si 0 0 0 0 si 0 0 0 0 si ♦si ♦si ♦ ♦ + + ♦
pH 9 ,6  Broth ♦ ♦ ♦ ♦ ♦ ♦ ♦ 0 0 0 0 0 0 ♦ + 0 0 0 0 0 0 0 ♦ 0 0 0
,1$  Meth­y lene Blue 
Milk 0 0 0 0 0 s i 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
6.5$ HaCl 
Broth 0 0 0 0 0 0 0 0 0 0 0 0 0 ♦ 0 0 0 0 0 0 0 0 0 0 0 0
40$ Bile 
Agar 0 s i s i 0 0 0 00 0 si 0 0 0 0 0 s i 0 0 0 0 0 0 0 s i 0 0 0
5% Sucrose 
Agar * 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ♦ 0
5% Sucrose 
Broth ** 0 0 0 0 0 0 0 0 0 0 ♦ 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Inulin *** 0 0 0 0 0 0 0 0 0 0 ♦ 0 0 0 0 0 0 0 0 0 0 ♦ ♦ 0 + 0
nh4 **** ♦ 0 0 0 +
♦ indicates growth in 24 hours unless otherwise indicated. 
0 * no * a m m « » n
* indicates formation of mucoid colonies.
** " increase in viscosity of broth.
*** " fermentation.
**** » production of ammonia in 4% peptone broth.
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3LE I
Lrldans Streptococci and Enterococci
SI ENTEROCOCCI
50 55 56 58 62 70 74 78 MG SBE 55 42 45 47 49 51 52 54 66 68 69 77 9790
0 0 0 0 0 0 0 0 0 0 ♦ 0 0 ♦ ♦ 0 0 0 + ♦ + 0 *
0 0 0 0 0 0 0 0 0 0 ♦ 0 0 + 0 ♦ 0 0 0 0 + 0 0
0 0 ♦ 0 0 0 0 0 0 0 ♦ ♦ ♦ + ♦ ♦ + + + ♦ 4 4- ♦
♦ si ♦ si ♦ ♦ ♦ + ♦ + ♦ ♦ + + + + + ♦ + + ♦
0 0 0 0 0 ♦ 0 0 0 + ♦ ♦ + + ♦ * ♦ ♦ + ♦ ♦ ♦
0 0 0 0 0 0 0 0 0 si + + + ♦ + + ♦ ♦ ♦ * ♦
0 0 0 0 0 0 0 0 0 0 ♦ + ♦ ♦ + ♦ ♦ + ♦ + + + ♦
0 0 0 0 0 si 0 0 0 0 ♦ ♦ + + ♦ ♦ ♦ ♦ ♦ + +■ ♦ +
0 0 0 0 0 0 0 ♦ 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
- o 0 0 0 0 0 0 0 0 ♦ 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 ♦ ♦ 0 ♦ 0 + 0 0 0 0  0 0 0 0 0 0 0 0 0
0 0 0 ♦ ♦
which does not agree with the findings of Sherman (abs, 1957) or 
Mirick et al. (1944), who found most of the viridans group grew at 
45*C. The explanation for this could be the difference under which 
the conditions of the test were carried out* Incubation at 45*C for 
24 hours was used in this study, while the other workers used incuba­
tion times of 7 days.
The litmus milk test was 100$ positive for the enterococci, but 
also almost 50$ positive for the viridans group. Similar results 
were found in the broth at pH 9.8.
The next three tests listed— 0.1a methylene blue milk, 6,5%
NaCl, and 405? bile agar— seemed to give the greatest correlation for 
both groups in addition to 45*C as stated earlier. All of the group 
tentatively designated as enterococci were positive for all three 
tests, while the viridans gave only a few slight reactions for the 
0.1$ methylene blue milk and 40$ bile agar, and one positive result 
for 6,5% NaCl broth.
It is interesting to note that the only organism found with the 
biochemical properties of an SBE streptococcus was from a nose and 
throat culture and not from any of the 8 blood cultures. Streptococcus 
W3BE" was first described and named as such because it was found in 
about 40$ of the cases of subacute bacterial endocarditis caused by 
various streptococci (Loews, et al., 1946). Since the only Strepto­
coccus "MG'* culture available to use as a control did not produce 
fluorescent colonies on 5% sucrose agar— a test described as diagnostic 
for this culture (Mirick, et al., 1944)— it did not seen worthwhile to 
test all the viridans group for this property.
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In view of present knowledge it would seem, best to use the S$ 
sucrose agar, 5$ sucrose broth, and iitulin for further subdivision of 
the viridans grotp. The main type at present which needs to be 
identified as soon as possible is Streptococcus BSB£W. The concentra­
tion of penicillin necessary to inhibit growth of this organism in 
the test tube bears little relation to the effective dosage in the 
human body. Therefore, patients known to be suffering from an infec­
tion due to Streptococcus WSBS” are given a much larger dosage of 
penicillin at the beginning of treatment (Loewe, Alture, and Werber, 
1946| Schlichter, McLean, and i&lzer, 1949),
The enterococci were not classified further into species or 
types, as there is still a question as to there being more than one 
species, S. fecalis (Evans and Chinn, 1947j Topley and Wilson, 1946).
Sensitivity Tests to Sulfathiatole and Four Antibiotics
Hie results of the sensitivity tests carried out on the 40 organ­
isms are shown in Table II. The results of the four best correlated 
biochemical tests are repeated in order to show the relationship be­
tween the biochemistry of the organisms under study and their sensi­
tivity to certain chemotherapeutic agents.
The sensitivity levels in Table II agree quite well with those 
found by other workers for viridans streptococci and enterococci 
(Bliss and Chandler, 1948j Bliss and Todd, 1949$ Jawitz, Gunnison and 
Coleman, 1950j Jawitz and Gunnison, 1950).
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TABLE II
Relation of the Biochemical Properties of Viridans Streptococci 
to Growth-Inhibiting Concentrations of Sulfathiagole, Aureomycin, Bacitracir
VIRIDANS STREPTOCOCCI
CULTURE # 1 4 5 17 23 27 34 57 11 16 18 25 30 39 40 46 48 50 55 56 58 62 70 74 78 MG
Biochemical Reactions
0.1$ Meth­
ylene 
Blue Milk 0 0 0 0 0 si 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
6.5* HaCl 0 0 0 0 0 0 0 0 0 0 0 0 0 + 0 0 0  0 0 0 0 0 0 0 0 0
40% Bile 
Agar 0 si si 0 0 0 0 0 si 0 0 0 0 0  si 0 0 0 0 0 0 0  si 0 0 0
45 *C 0 0 0 0 0 0 0 0 0 0 0 0 o o o o o o o ♦ o o o 0 0 0
Inhibiting Concentrations
Sulfa­
thiasole * .1 .1 . 1 .1 .1 1 5 .1 1 .1 .1 5 1 .1 .1 .1 .1.01 1 .1.01 1 10 .1.01 10
Aureo- 
aycin ** .1 .1 .1.01 .1 .1 .1 .1 .i.ca .i .i .1 .1 .1.01 .1 .1 .1 .1 .1 .1 .5 .5 .5 .5 4
Baci­
tracin .1.01.01.001.01,01.1.01 .1.01.01.01 .1.01 .1.01.01.01 .1.01.01.01 .1 .1 .1 .l.C
Peni­
cillin *** .5 .1 .5 .1 ..1 5 ,.1 .1 .1.01.01 .1 1 *1 .1.01 .1 .1.01 .1 .1 .1 .1 .1 .1 .1 .
Strepto­
mycin** 5 5 5 1 5 10 1 1 1 5  5 5 5 1 5 5 5 5 5 5 1  .5 1150 5 1
* inhibiting concentration in mg/cc 
** * m m  u g/ c c
*** m m m  units/cc
si » slight reactions
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TABLE II
Properties of Viridans Streptococci and Enterococci 
ilfathiazole, Aureomycin, Bacitracin, Penicillin, and Streptoaycin
PTOCOCCI ENTEROCOCCI
40 46 48 50 55 56 58 62 70 74 78 MG SBE 55 42 45 47 49 51 52 54 66 68 69 79 9790
Biochemical Reactions
.1 .1 .1.01 1 .1.01 1 10 .1.01 10 1 30+30+30+30 50 50 20 20+50 20 50 30 ♦30
.1.01 .1 .1 .1 .1 .1 .1 .5 .5 .5 .5 .1 • S •S •S •5 .5 .1 .5 .5 1 .5 .5 5 5
.1.01.01.01 .1.01.01.01 .1 .1 .1 .1.001 • 5 *1 «1 «1 .1 .5 .1 .5 1 .5 .5 1 .5
.1.01 .1 .1.01 .1 .1 .1 .1 .1 .1 .1 .1 5 5 10 5 5 20 10 5 .5 5 5 5 10
5 5 5 5 5 5 1 .5 1 50 5 1 5 100 50 50 50 50 100 50 100 100100100100 50
Summarising the results of table U* in Table in are the median 
'values of eaeh antibiotic and sulfathiasole for the viridans strepto­
cocci and the enterococci.
TABLE III
Median Values of fbrowth-Inhlbitlng Concentrations of Sulfathiasole, 
Aureaayciri', jBacitracin,.Penicillin,.snd lltreptamycln
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VIRIBAHS STREPTOCOCCI ENTEROCOCCI
Sulfathiasole* .1 50.
Aureomycin** ♦1 .5
Bacitracin** .01 .5
Penicillin*** .1 5.
Streptomycin** 5. 100.
* inhibiting concentration in mg/cc 
** " n n ug/cc
•»«-» »■ » « units/cc
A study of these values indicates that the enterococci are, in 
general, more resistant to all of the agents tested. The least in­
crease is shown for aureoraycin and streptomycin, the greatest for 
sulfathiasole. A comparison of these in vitro values to those clini­
cally found treatable by other investigators (Meter, 1958j Rants and 
Kirby, 1943} Fleming, 1929} Bornstein, 1940; Heilman and Herrell, 1942} 
Watson, 1944} Jawits, Qumison, and Coleman, 1950} Bliss and Todd, 
1949) indicates that the enterococci would be resistant to treatment 
with sulfathiasole, penicillin, and streptomycin, but might be ex­
pected to respond to aureoaycin and bacitracin. The viridans group 
show an in vitro level which indicates that any of the 5 agents might 
be effective for treatment.
The difference between the inhibiting concentrations of sulfa- 
thiaaole and penicillin for the two grosqps was of great enough magnitude 
that it seemed sane value might be chosen between that for viridans and 
that for enterococei which would laake a useful test for differentia­
tion* Different concentrations of sulfathiazole and penicillin w ere 
tried in preliminary experiments, and it was found that to differen­
tiate between viridans streptococci and enterococci, tPB broth contain­
ing 10 mg/cc of sulfathiazole, and TPB broth containing 2 units/cc of 
penicillin seemed to give the most clear-cut results. The choice of 
these values may se*a rather high in view of the definite antibiotic 
levels, but in these tests it was desirable to use 1 drop of an 18-24 
hour culture of the organism without adjusting the size of the inoculua 
as was done in the sensitivity test.
Five cubic centimeters of TPB containing sulfathiaaole or peni­
cillin in the concentrations given above were inoculated and each 
tube was incubated for 57*G for 18-24 hours, and any turbidity read 
as a positive test. These taro tests proved very successful in 
separating the viridans streptococci from the enterococci already 
classified by biochemical tests, and are highly correlated wit* the 
three better biochemical tests. This is shown in Table IV.
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Correlation of Three Biochemical Tests with Sulfathiazole 
and Penicillin Sensitivity
SI
TABLE IV
DIFFERENTIAL TEST IS 0JTEROCOCCI 27 r m m a s  streptococci
0*1$ Methylene Blue 
Milkt ' , ; IS * 2 (si)
6.52 IfeCl IS 1
40$ Bile Agar IS 5 (si)
10 mg/cc Sulfathiazole IS 2
2 units/cc Penicillin 
Broth 13 1
* number with positive test 
si - slight reaction
Therefore, if these two tests were U3ed in addition to the three 
biochemical tests— 0.1$ methylene blue, 6.5$ Had, and 40$ bile agar- 
one would have not only five correlated biochemical tests for differen­
tiating enterococci from viridans, but also would have an indication at 
the very first of the resistance of the organism. This would prove 
valuable, both to the bacteriologist in the diagnostic laboratory and 
also to the clinician in starting chemotherapeutic measures.
(B) Resistant Strains Developed in vitro 
Methods
Strains of viridans streptococci resistant to sulfathiazole, 
aureoraycin, penicillin, and streptomycin were prepared by continuous
serial subculture in TFB in the presence of increasing concentrations 
of the cheaotherapeutic agents named. The first 8 of the 2? viridans 
streptococci listed in Table I were used in developing these resistant 
variants* The final number of resistant variants developed were as 
follows: sulfathiasole 8, aureoraycin 8, penicillin 5, and strepto­
mycin 6. Strains resistant to bacitracin did not develop, even though 
subcultured many times. Each resistant variant was inoculated into 5 
differential media in the same way as described previously for the 
streptococci isolated from human sources. However, the sulfathiaaole 
broth of 10 mg/cc or the penicillin broth of 2 units/cc was not used, 
since preliminary sensitivity levels done on most of the resistant 
variants gave levels to both penicillin and sulfathiazole beyond the 
range of these tests. Sensitivity levels were determined to sulfathia- 
aole and the 4 other antibiotics as before.
The free glutamic acid content of viridans streptococci, entero- 
cocci, and representative resistant strains was determined because Gale 
(1948) had shown with 4 strains of Staphylococcus aureus that there is 
a correlation between sulfathiazole resistance and the height of the 
level of free glutamic acid in fee young cells. The method used for 
determining the glutamic acid content of the cells of the different 
resistant variants was that developed by Gale (1945). This method 
depends upon manometric measurement of CO^  liberated from the amino 
acid by the specific decarboxylase for that acid at the optimum pH and 
temperature for that decarboxylase. The glutamic acid decarboxylase 
used here was obtained from a 12-16 hour culture of Clostridium 
welchii, SR 12, which had been shewn by Gale (1945) to be specific for 
l~glutamic add. The Clostridium welchii was grown in 800 cc of TPB
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plus 0.1$ yeast extract and 2$ glucose. After 12-16 hours the organ­
isms were harvested, washed twice in distilled water, and node up to 25 
cc with U/5 acetate buffer of pH 4.5, which is the optimum pH for this 
decarboxylase. Each organism was grown in 500 cc of TPB plus 0.1$ 
yeast extract, and harvested at different times, washed twice with dis­
tilled water, and made up in about 3,5 cc of distilled water. The cell 
suspension was divided into two parts— one was used as a control, the 
other was placed in boiling water for 10 minutes to release free glu­
tamic acid inside the cell. One cubic centimeter of the control was 
put in a crucible, dried and -weighed. Into the well of each Warburg 
flask wa3 measured 1 cc of the cell suspension, 1.2 cc of M/5 acetate 
buffer, and into the side arm was measured 1 cc of the decarboxylase 
preparation. Each determination was done in duplicate.
Since Gale (1947) had shown that the free glutamic acid content of 
S. fecalis varied at different times in the growth cycle, by preliminary 
experiments covering the whole growth curve, It was found that maximisa 
values of free glutamic acid would be found at the times chosen in our 
experiments.
Results
Biochemical Tests Used for Classification and Their Correlation
The aureomycin, penicillin, and sulfathiasole-reslstant variants 
were all positive for 0.1;? methylene blue milk, 6.5$ SaCl, and 40$ 
bile agar, thus resembling the enterococci in biochemical character­
istics. However, the streptomycin-resistant strains showed consider­
able variation. These results are shown in Table ?.
Blochealcal Properties of Strep tonycin-Iiesistant Variants of
VirlSans Streptococci “
TABLE V
Culture # . . . . . . . .  . . 1 4 6 1? 25 s?; v - •> .-ri '
Fold increase in resistance 
to Streptoaycin 200 200 200 1,000 1,000 10f000
0.l£ Methylene Blue Milk 0 0 0 0 0 *
8.5$ Had 0 ♦* • + + 0 ♦
4Qjb Bile Agar + ♦ 0 0 ♦ ♦
Sensitivity Tests of Resistant Variants to Sulfathiasole and 4 Antibiotics
The results are shown as followst
Sulfatfciasole-resistant variants - Table VI 
Aureoaorcin-resistant variants - " VII 
Penicillin-resistant variants - " VIII 
StreptCH^ jrcin-resistant variants " IX
TABLg VI 
Sulfathiaaole-Resistant Variants
Growth-Inhibiting Concentrations of Sulfathlazole» Aureoaycin, Bacitracin, P<
Culture
Humber
SULFATHIAZOLE* AURE0MYCIN** BACITRACIN**
Parent
Strain
Resistant
Variant
Fold
Increase
Parent
Strain
Resistant
Variant
Fold
Increase
Parent
Strain
Resistant
Variant
Fold
Increase
Pi
SI
1 .1 ♦ 50 500 .1 1. 10. .1 .1 0
4 .1 ♦ 50 500
(__— _  ._|
.1 .5 5. ! .01 .05 5
6 .1 ♦ 50 500 .1 .5 5. .01 .05 5
17 .1 ♦ 50 500 .01 1. 100. .001 .05 50
25 .1 ♦ 50 500 .1 .5 5. .01 .05 5
27 1. ♦ 50 50
t.r,n i i i^
.1 1. 10. .01 .05 5
54 5. ♦ 50 6 .1 .5 5. .1 .1 0
57 .1 ♦ 50 500 .1
_______1
1. 10. .01 .5 50
* inhibiting concentration in mg/cc 
*» * * « xig/cc
**$♦ « m m  units/cc
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TABLE VI 
.thiaisole-Resistant Variants
.thiazole, Aureoaycin, Bacitracin, Penicillin, and Streptomycin
BACITRACIN** PENICILLIN***
i
i
STREPTOMYCIN**!
Fold
Increase
Parent
Strain
Resistant
Variant
Fold
Increase
Parent
Strain
Resistant
Variant
Fold
Increase
Parent
Strain
Resistant
Variant
Fold
Increase
10. .1 .1 0 .5 10 20 5. 25 5
5. .01 .05 5 .1
|
10 100 5. 25 5
5. .01 .05 5 .5 10 20 5. 25 5
100. .001 .05 50 .1 10 : 100 1.
I..1 —
25 25
5. o• .05 5 .1 10 100
1
5. 25 5
10. .01 .05 5 5 10 2 10. 25 2.5
5. .1 .1 0 .1 10 100 1. 25 25
10. .01 .5 50 .1 10 100 1. 100 100
TABLE ¥11 
Aureomycin-Resistant Variants 
Growth-Inhibiting Concentrations of Aureomycin, Sulfathiazole t Bacitracin, Pei
Culture
Number
AUREOMYCIN** SULFATHIAZOLE* BACITRACIN**
Parent
Strain
Resistant
Variant
Fold
Increase
Parent
Strain
Resistant
Variant
Fold
Increase
Parent
Strain
Resistant
Variant
Fold
Increase
Pa
St
1 .1 10 100 .1 * 50 500 .1 .1 0
4 .1 10 100 .1 ♦ 50 500 d• .5 50
6 .1 50 300 .1 ♦ 50 500 .01 .5 50
17 .01 20 2,000 ,1 ♦ 50 500 .001 .5 500
27 .1 10 100 1 ♦ 50 50 .01 .5 50
57 .1 10 100 .1 ♦ 50 
___ 1
500 .01 .5 50
* inhibiting concentration In mg/cc-R*S- " u r n  ug/cc
**#• » » " units/cc
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TABLE VII 
lut eomy c in-Re sis tan t Variants
tomycin, S^ ifathiazole, Bacitracin, Penicillin, and Streptomycin
j&Sr BACITRACIN** PENICILLIN*** STREPTOMYCIN**
Fold
Increase
Parent
Strain
Resistant
Variant
Fold
Increase
Parent
Strain
Resistant
Variant
Fold
Increase
Parent
Strain
Resistant
Variant
Fold
Increase
500 .1 .1 0 .5 10 20 5 20 4
500 • o H .5 ; 50 .1 5 50 5 50 6
500 .01
i
.5 50 .5 5 10I
5 20 4
500 .001 .5 500 .1 5 50 1 5 50
50 .01 .5 50 .1 5 50 10 100 10
500 
1 -..—-----
.01 .5 50 .1 5 50 1 100
i * ’
100
TABLE VIII 
Penlcillin-Resi stant Variants 
Growth**Inhibiting Concentrations of Penicillin, Sulfathiatole, Aureomycin, Ba<
Culture
PENICILLIN*** SULFATHIAZOLE* AURE0MYCB
Humber
Parent
Strain
Resistant
Variant
Fold
Increase
Parent
Strain
Resistant
Variant
Fold
Increase
Parent
Strain
Resistant
Variant
Fold
Increase
Paj
Sti
1 .5 200 400 .1 20 200 ,1 1 10
4 .1 100 1,000 .1 ♦ 30 500 .1 1 10
6 .5 200 400 .1 ♦ 50 500 .1 .5 5
17 .1 100 1,000 .1 + 50 500 .01 1 100
57 .1 100 1,000 .1 ♦ 50 500 .1 5 5
# inhibiting concentration in mg/cc 
#* " * H ug/cc
*#* « b w units/cc
57
TABLE VIII 
icillln-flesl stant Variants
illin, £athia»ole, Aureomycln, Bacitracint and Streptomycin
;* AUREOMYCIN** BACITRACIN*-# STREPT0HTC3»**
Fold
[ncrease
Parent
Strain
Resistant
Variant
Fold
Increase
Parent
Strain
Resistant
Variant
Fold
Increase
Parent
Strain
Resistant
Variant
Fold
Increase
200 .1 1 10 .1 .1 0 5 5 0
300 .1 j 1 10 .01 .05 5 5 5 0
500 .1 .5 5 .01 .05 5 5 5 0
500 .01 1 100 .001 .1 100 1 5 5
500 .1
...........
5 5 .01 .5 50 1 100 100
TABLE IX 
Streptoaycin—Resistant Variants 
Growth-Inhibiting Concentrations of Streptomycin. Sulfathiazole. Aureomycin, ]
Culture
STREPTOMYCIN** SULFATHIAZOLE* AUREOMYCIN**
Number
Parent Resistant Fold Parent Resistant Fold Parent Resistant Fold PaiStrain Variant Increase Strain Variant Increase Strain Variant Increase St-i
1 5 1,000 200 .1 .5 5 .1 .1 0 «
4 5 1,000 200 .1 .5 5 | .1 .1 0 «
6 5
________
5,000 200 .1 .5
‘
5 .1 .5 5 4
17 1 5,000 5,000 .1 5 5 .01 .5 50 •
25 5 5,000 1,000 .1 5 5 .1 .5 5 •
57 1 +10,000 10,000 .1 +30 30 .1 1 10 •
* inhibiting concentration in ag/cc
** " » * Ug/CC
*** » ■ ■ units/cc
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TABLE IX 
tomycin-Resistant Variants
anycin, Sulfathiazole t Aureanyein, Bacitracin, and Penicillin
b* AUHEOMYCIN** BACITRACIN** PENICILLIN***
fold
crease
Parent
Strain
Resistant
Variant
Fold
Increase
Parent
Strain
Resistant
Variant
Fold
Increase
Parent
Strain
Resistant
Variant
Fold
Increase
5
.1 .1 0 .1 .1 0 .5 .5 0
"I15 .1 .1 0 .01 .01 0 .1 .5 5
5 .1 .5 5 .01 .05 5 .5 .5 0
5 .01 .5 50 .001 .01 10 .1 .5 5
5 .1 .5 5 .01 .1 10 .1 .5 5
30 .1 1 10 .01 2 200 .1 5 5
Table VI shows that half of the aulfathiazole-resistant -variants 
increased 10 fold or more in their resistance to aureojnycin, and all 
but 1 of the 8 increased 20 fold or more to penicillin. The increased 
resistance shown to bacitracin and streptomycin is considerably less. 
Table VII shows a decided increase of resistance in most of the aureo- 
igycin-resistant variants to sulfathiasole, penicillin, and bacitracin, 
with a definitely smaller increase of resistance to streptomycin. In 
Table VIII we find the penicillin-resistant variants to show some 
increase in resistance to bacitracin and aureomycln, very similar in 
magnitude to that of the sulfathiasole-resistant variants. Again, 
there is in all cases but one little or no increase in resistance to 
streptomycin. The streptomycin-resistant variants (Table IX), while 
showing some small increases with individual strains, in general had 
little increase in resistance to sulfathiasole, aureomycin, bacitra­
cin, or penicillin. It is interesting that it is streptomycin resis­
tance which does not accompany other resistance increases wit* any 
of the variants, either the ones trained to resistance against strep­
tomycin, or those trained to resistance to sulfathiasole or the other 
antibiotics. This difference in streptomycin-resistant trained strains 
was also observed in their biochemical properties which were variable, 
while those of all the other trained strains resembled the enterococci.
The results shown in these four tables may be of some value as a 
preliminary suggestion for the best antibiotic or combination of 
agents to treat a viridans or enterococcus resistant to any of the 
agents discussed. For exaaple, bacitracin might be expected to be 
more effective than others against sulfathiasole and penicillin-resis- 
tant strains, and any of the four might still be active in inhibiting
growth of the streptomycin-resistant strains, they may also indicate 
what kind of resistance may be expected if such organisms merge 
under treatment. Bie results do show that, although most reports 
have indicated no cross-resistance for sulfathiasole and the better 
known antibiotics, this group of organisms shows a great deal of 
cross-resistance, even though the magnitude of the increase in many 
cases was not very great. Finally, the survey shows that there is 
considerable variation in the response to other antibiotics and in 
biochemical properties, depending upon the agent which has brought 
about idie increased resistance and the organism whose resistance has 
been increased.
Free Glutamic Acid Content
The results of the free glutamic acid content determined mano— 
metrically are given in Table X. The free glutamic acid eontent of 
the cells is greatest at the time when they have Just reached maximum 
growth. This was also reported by Gale (1947 a). Gale had noted that 
a few sulfathiasole-resistant organisms appeared to have higher con- 
centractions of glutamic add. The results show all the susceptible 
viridans strains to have no free glutamic acid, while two strains of 
H* fscalls and all 8 sulfathiaaole-resistant strains had very appre­
ciable amounts. The aureomycin and penicillin-resistant trained strains 
also showed a high internal concentration of free glutamic acid, 
which might be expected if all sulfathiaaole-resistant variants have 
a high content, since sulfathlaaole—reslstance did increase as aureo— 
B*ydn and panicillin-resistance developed. All but one of the strep­
tomycin-resistant strains showed no glutamic add. This single strain
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was also the only one in which an increase in resistance to 
aulfathiasole was observed.
t; v i, '•■■■': i '■ , >■.; j. > .. , "■ i {).
• ' - - • . ' • . j • : ' • ■ • < ■ ■ ■ ■- . ' ! ' ' -i • •: *
, y l-f ; : : ;V. ; . v-'vy ; /■• . >
» ' “
Glutamic Acid in Internal Environment 
(ul/lOO mg cells)
TABLE X
Hours of Growth at 37*C
CULTURE NUMBER
6 8 10-12
Viridans........ ............ 1 I 0 04 0 0,0 06 0 0,017 025
27
54 057
18 0,0 046 0 0
S, fecalis................  9790 172, 165 452, 246 500,20547 68, 156 115, 260 175, 162
Sulfathiasole-Resistant Variant ... 1 168 129, 220 149, 1454 142 166, 128 521, 1816 228, 226 261, 511 254, 20517 157, 154 257, 16825 US 18027 170 20154 100 20157 284 599 555
Aureooycin-Resi stant Variant...  1 547 5514 208 2546 258 26217 158 18757 179 555 254
Penicillin-Resistant Variant ..... 1 129 1754 572 5786 501 25417 290 20457 508 528
Streptomycin-Resistant Variant ... 1
4
6
17
25
57 588 509
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TABLE X
d in Internal Environment 
7100 mg cells)
8 10—12 16-18 24 56
0 0 0,0 0,0
0,0 0 0 0*0 0,0 0,0 00 0 0,00
0
0 0 0,00
0,0
0
0 0 0
0
0,0
452, 246 500,205 287 265
115, 260 175, 162
129, 220 149, 145 120 105
166, 128 521, 181 124, 92
261, 511 254, 205 118 68257, 168 107,114 284
118 180 115
170 201 135
201 111
599 555 132
547 551 270
208 254 80
258 262 255187 174
555 254 159
129 175 107
572 578 560
501 254 161204 140
508 528 185
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
588 509 147
To show more clearly the relationship of glutamic acid content of 
the parent strains to the resistant variants, the values for organism 
#1 (which is typical of all other findings) are plotted graphically 
in Table XI.
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IV. CONCLUSIONS 
Biochemical Properties and Resistance
The biochemical characteristics best suited for differentiating 
between viridans streptococci and enterococci as indicated by this 
study of 40 streptococci are* growth in broth incubated at 45*C for 
24 hours, the reduction of 0.1$ methylene blue milk, growth in 6.5^
SaCl broth, and growth on 40,? bile agar. To date, the importance of 
identifying the various types of viridans streptococci is still 
open to question. Streptococcus "SEE", the only type of viridans which 
has been found to be more resistant in vivo than the in vitro Inhibitory 
concentrations indicate, is identified by its ability to jell $% 
sucrose broth and to ferment inulin. Because of the resistance this 
type shows in vivo, a specific differentiation from other members of 
the viridans group mi^t well be made in the laboratory so the 
clinician can adjust the in vivo level of penicillin accordingly.
The enterococci were more resistant to sulfathiasole, penicl31in, 
streptomycin, aureoreycin, and bacitracin than the viridans strepto­
cocci. The much greater resistance of the enterococci to sulfathia­
sole and penicillin indicated the possibility of using definite concen­
trations of these in broth as criteria for identification. These two 
tests alone might be used for a quick, practical, and early test. At 
least, these two tests should be added to the four tests previously 
named as being the best for differentiation.
Indications from these in vitro tests are that infections due to 
viridans might respond to all of the chemotherapeutic agents tested 
but those due to enterococci might best be treated with bacitracin or 
aureomycin.
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Resistant Strains Developed in vitro
The most interesting findings in the development of resistant 
strains was the cross-resistance, and the difference between the strep** 
tomycin-resistant variants as compared to the others. This may be re­
lated to the fact that streptomycin resistance develops rapidly, 
while resistance to sulfathiasole and the other antibiotics develops 
more slowly in step-wise fashion according to Demerae (1948). The 
variant strains selected by sulfathiasole, aureoaycin, and penicillin 
all show the same biochemical properties as a typical enterococcus. 
Those selected by streptomycin vary in their biochemical properties 
and often do not have the properties of enterococci. This may be a 
further indication that the agent determines the kind of variant and 
does not select naturally-occurring mutants that would be found even 
in the absence of the agent.
Glutamic Acid Content
The results of the glutamic acid determinations show that 
appreciable amounts are found free inside those cells which have ac­
quired sulfathiasole resistance. Whether that resistance has been 
induced by sulfathiasole or accompanies increased resistance to other 
agents makes no difference. It may be, as Gale has suggested, that 
the glutamic acid inside the cells reverses the sulfonamide action 
since it has been shown to be capable of doing this for some cells 
when added to the external environment. In the two resistant strains 
of Staphylococcus aureus studied by Gale and Bodwell (1948), a higher 
content of glutamic acid was observed only in the early growth phase. 
Later at the and of the active growth the content of two susceptible
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strains was found to be higher than that of one of the resistant 
strains. The resistant strains used were naturally resistant, while 
those reported in this study had been trained to resistance.
Whether the resistance is due to the increase in internal glutamic 
acid, or whether this is merely a result of other changes which de­
termine the organism's resistance, is of course not answered by this 
study# This ability to concentrate glutamic acid was also shown by 
two strains of S. fecalis, and adds another property common to sulfa- 
thiaasole-resistant organisms and S, fecalis. It is very interesting 
that the viridans group showed no free glutamic acid at any stage of 
growth, since Gale found all gram positive organisms to be capable 
of accumulating this acid inside the cell.
v. m m x i
1* Reduction of 0.1* methylene blue milk, growth on 40$ bile 
agar, in 6.5;? UaCl broth, in broth at 45*C, in sulfathiasole broth of 
10 mg/cc, and in penicillin broth of 2 units/cc were the biochemical 
tests which correlated best for differentiating: the viridans strepto­
cocci from the enterococci*
2. Sensitivity tests in vitro indicated that the enterococci 
were more resistant to sulfathiazol®, penicillin, streptomycin, aureo- 
mycin, and bacitracin than the viridans group. The concentrations 
required to inhibit growth suggested that the viridans streptococci 
might respond to treatment with all of the chemotherapeutic agents, 
but the enterococci only to aureomycin and bacitracin.
S. Cross-resistance was observed in most resistant strains for 
all agents. However, streptomycin-resistant strains showed con­
siderable variation, both as to cross—resistance and biochemical 
properties.
4, Organisms acquiring sulfathiazole resistance, either by 
growing in sulfathiasole or in the antibiotics, showed appreciable 
quantities of free glutamic acid, which was highest at the period 
when the organisms had just reached maximum growth. This was also 
observed with S. fecalis. AH non-resistant strains of the viridans 
group showed no glutamic acid inside the cells at any growth phase.
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